Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 05, 2021

SELL
$15.42 - $21.72 $7,710 - $10,860
-500 Closed
0 $0
Q2 2021

Aug 12, 2021

BUY
$20.85 - $29.88 $10,425 - $14,940
500 New
500 $10,000
Q1 2021

May 24, 2021

SELL
$24.75 - $39.14 $0 - $0
0 Closed
0 $0
Q4 2020

Feb 09, 2021

SELL
$29.0 - $41.62 $3,335 - $4,786
-115 Closed
0 $0
Q3 2020

Nov 16, 2020

BUY
$16.3 - $30.64 $1,874 - $3,523
115 New
115 $4,000

Others Institutions Holding KURA

About Kura Oncology, Inc.


  • Ticker KURA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 66,893,000
  • Market Cap $722M
  • Description
  • Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...
More about KURA
Track This Portfolio

Track Advisory Services Network, LLC Portfolio

Follow Advisory Services Network, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisory Services Network, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Advisory Services Network, LLC with notifications on news.